Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

26 May 2006 08:56

Tristel PLC26 May 2006 Tristel plc 26 May 2006 Director/PDMR Shareholding Tristel plc ("Tristel"), the healthcare business which uses its proprietarychlorine dioxide chemistry to create infection control products for hospitalsannounces the following share purchases by directors: On 25 May 2006 Peter Stephens (Non-Executive Director) acquired 10,000 shares at43 pence each, taking his total shareholding to 583,937 shares (2.4%). On 25 May 2006 Paul Barnes (Finance Director) acquired 5,000 shares at 43 penceeach, taking his total shareholding to 556,260 shares (2.3%). ENDS Tristel plc Parkgreen Communications Ltd Paul Swinney, Chief Executive Paul McManusPaul Barnes, Finance DirectorTel: 01638 721500 Tel 020 7786 9600http://www.tristel.com Mob: 07980 541 893 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.